A new, accurate screening test for malignant pleural mesothelioma (MPM) has been developed by Rosetta Genomics, a molecular diagnostics company. The test uses genetic material known as microRNA found in tissue samples to identify MPM and distinguish it from other pleural carcinomas. According to the research company the microRNA test is incredibly accurate, and is [...]
Archive for September, 2010
September 30 2010
New Mesothelioma Biomarkers Discovered During Study
According to results of a study recently presented at the Fourth American Association for Cancer Research (AACR) International Conference on Molecular Diagnostics in Cancer Therapeutic Development, researchers have identified biomarkers that are specific to pancreatic cancer and malignant pleural mesothelioma.
The biomarkers were discovered using the new aptamer-based proteomics array technology, which was developed by SomaLogic [...]